GIANNI, ALESSANDRO
GIANNI, ALESSANDRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
2021 S. Cortelazzo, M. Mian, A. Evangelista, L. Devizzi, P. Corradini, M. Magni, M. Ladetto, S. Ferrero, A. Rossi, A.M. Barbui, C. Patti, A. Costa, U. Vitolo, A. Chiappella, F. Benedetti, A.J.M. Ferreri, P. Nicoli, L. Rigacci, C. Castellino, A.M. Gianni, A. Rambaldi, C. Tarella
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
2020 P. Tacchetti, L. Pantani, F. Patriarca, M.T. Petrucci, E. Zamagni, L. Dozza, M. Galli, F. Di Raimondo, C. Crippa, M. Boccadoro, S. Barbato, P. Tosi, F. Narni, V. Montefusco, N. Testoni, A. Spadano, C. Terragna, N. Pescosta, G. Marzocchi, C. Cellini, P. Galieni, S. Ronconi, M. Gobbi, L. Catalano, A. Lazzaro, G. De Sabbata, C. Cangialosi, F. Ciambelli, P. Musto, F. Elice, M. Cavo, R. Fanin, R. Foa', A. Rambaldi, G. Rossi, P. Leoni, P. Corradini, G. Torelli, G. Fioritoni, S. Cortelazzo, G. Lambertenghi Deliliers, G. La Nasa, A. Zaccaria, P. De Fabritiis, N. Cascavilla, A. Bosi, G. Semenzato, L. Gugliotta, F. Gherlinzoni, E. Angelucci, M.F. Martelli, M.C. Petti, G. Leone, A.M. Carella, F. Ciceri, A. Santoro, F. Ferrara, F. Nobile, A.M. D'Arco, A. Levis, L. Guardigni, A. Gallamini, P.P. Fattori, S. Morandi, D. Amadori, B. Rotoli, S. Mirto, G. Paladini, R. Mozzana, G. Pinotti, F. Rodeghiero, N. Cantore, V. Pavone, E.M. Pogliani, A.M. Liberati, I. Majolino, S. Amadori, F. Lauria, M. Aglietta, G. Quarta, S. Storti, F. Morabito, S.F. Capalbo, A.M. Gianni, V. Mettivier, V. Rizzoli, C. Bernasconi, G. Visani, M. Pizzuti, G. La Verde, G. Avvisati, M. Longinotti, E. Gallo, F. Dammacco, D. Russo, A. Bacigalupo, C. Musolino
Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue (Annals of Oncology (2018) 29 (2363-2370) DOI: 10.1093/annonc/mdy450)
2019 S. Ciavarella, M.C. Vegliante, M. Fabbri, S. De Summa, F. Melle, G. Motta, V. De Iuliis, G. Opinto, A. Enjuanes, S. Rega, A. Gulino, C. Agostinelli, A. Scattone, S. Tommasi, A. Mangia, F. Mele, G. Simone, A.F. Zito, G. Ingravallo, U. Vitolo, A. Chiappella, C. Tarella, A.M. Gianni, A. Rambaldi, P.L. Zinzani, B. Casadei, E. Derenzini, G. Loseto, A. Pileri, V. Tabanelli, S. Fiori, A. Rivas-Delgado, A. Lopez-Guillermo, T. Venesio, A. Sapino, E. Campo, C. Tripodo, A. Guarini, S.A. Pileri
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue
2018 S. Ciavarella, M.C. Vegliante, M. Fabbri, S. De Summa, F. Melle, G. Motta, V. De Iuliis, G. Opinto, A. Enjuanes, S. Rega, A. Gulino, C. Agostinelli, A. Scattone, S. Tommasi, A. Mangia, F. Mele, G. Simone, A.F. Zito, G. Ingravallo, U. Vitolo, A. Chiappella, C. Tarella, A.M. Gianni, A. Rambaldi, P.L. Zinzani, B. Casadei, E. Derenzini, G. Loseto, A. Pileri, V. Tabanelli, S. Fiori, A. Rivas-Delgado, A. López-Guillermo, T. Venesio, A. Sapino, E. Campo, C. Tripodo, A. Guarini, S.A. Pileri
Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles : long-term results of the GITIL/FIL HD 0607 trial
2018 A. Gallamini, C. Tarella, S. Viviani, A. Rossi, C. Patti, A. Mulé, M. Picardi, A. Romano, M. Cantonetti, G.L. Nasa, L. Trentin, S. Bolis, D. Rapezzi, R. Battistini, D. Gottardi, P. Gavarotti, P. Corradini, M. Cimminiello, C. Schiavotto, G. Parvis, R. Zanotti, G. Gini, A.J.M. Ferreri, P. Viero, M. Miglino, A. Billio, A. Avigdor, A. Biggi, F. Fallanca, U. Ficola, M. Gregianin, A. Chiaravalloti, G. Prosperini, F. Bergesio, S. Chauvie, C. Pavoni, A.M. Gianni, A. Rambaldi
Brentuximab Vedotin in CD30-Positive Lymphomas : a SIE, SIES, and GITMO Position Paper
2015 P.L. Zinzani, P. Corradini, A.M. Gianni, M. Federico, A. Santoro, U. Vitolo, G. Barosi, S. Tura
HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma
2015 R. Zappasodi, G. Ruggiero, C. Guarnotta, M. Tortoreto, C. Tringali, A. Cavanè, A.D. Cabras, L. Castagnoli, B. Venerando, N. Zaffaroni, A.M. Gianni, F. De Braud, C. Tripodo, S.M. Pupa, M. Di Nicola
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
2014 A. Guidetti, C. Carlo-Stella, S.L. Locatelli, W. Malorni, R. Mortarini, S. Viviani, D. Russo, A. Marchianò, R. Sorasio, A. Dodero, L. Farina, L. Giordano, M. Di Nicola, A. Anichini, P. Corradini, A.M. Gianni
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib : the role of circulating interleukin-8 to enhance the prognostic accuracy
2014 A. Necchi, M. Pennati, N. Zaffaroni, E. Landoni, P. Giannatempo, D. Raggi, L.H. Schwartz, C. Morosi, F. Crippa, E. Farè, N. Nicolai, R. Lanocita, T. Sava, C. Sacco, C. Messina, C. Ortega, F.G. De Braud, R. Salvioni, M.G. Daidone, A.M. Gianni, L. Mariani
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry
2014 P. Pedrazzoli, G. Martinelli, A.M. Gianni, G.A. Da Prada, A. Ballestrero, G. Rosti, G.L. Frassineti, M. Aieta, S. Secondino, S. Cinieri, R. Fedele, C. Bengala, M. Bregni, D. Grasso, U. De Giorgi, F. Lanza, L. Castagna, B. Bruno, M. Martino
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis
2014 M. Magni, M.D. Nicola, C. Patti, R. Scimè, A. Mulè, A. Rambaldi, T. Intermesoli, P. Viero, C. Tarella, A. Gueli, L. Bergui, L. Trentin, A. Barzan, F. Benedetti, A. Ambrosetti, F. Di Raimondo, A. Chiarenza, G. Parvis, A. Billio, I. Attolico, A. Olivieri, M. Montanari, C. Carlo-Stella, P. Matteucci, L. Devizzi, A. Guidetti, S. Viviani, P. Valagussa, A.M. Gianni
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
2013 V. Ribrag, D. Caballero, C. Fermé, E. Zucca, R. Arranz, J. Briones, C. Gisselbrecht, G. Salles, A.M. Gianni, H. Gomez, C. Kahatt, C. Corrado, S. Szyldergemajn, S. Extremera, B. de Miguel, M. Cullell Young, F. Cavalli
HSP105 inhibition hampers the growth of human aggressive B-cell non-Hodgkin lymphoma by counteracting key oncogenic pathways
2013 R. Zappasodi, A. Cavané, M. Tortoreto, C. Tringali, A.D. Cabras, G. Ruggiero, L. Castagnoli, B. Venerando, N. Zaffaroni, S.M. Pupa, A.M. Gianni, M. Di Nicola
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma : the Italian experience and results of its use in daily clinical practice outside clinical trials
2013 P.L. Zinzani, S. Viviani, A. Anastasia, U. Vitolo, S. Luminari, F. Zaja, P. Corradini, M. Spina, E. Brusamolino, A.M. Gianni, A. Santoro, B. Botto, E. Derenzini, C. Pellegrini, L. Argnani
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy
2013 A. Rambaldi, C. Boschini, G. Gritti, F. Delaini, E. Oldani, A. Rossi, A.M. Barbui, D. Caracciolo, M. Ladetto, A. Gueli, A. De Crescenzo, R. Passera, L. Devizzi, C. Patti, A.M. Gianni, C. Tarella
Successful second autologous engraftment after long duration storage of hematopoietic stem cells
2013 P. Longoni, M. Milanesi, M. Di Nicola, L. Devizzi, M. Carrabba, F. Arienti, F. Ravagnani, C. Tarella, V. Montefusco, A. Gianni, P. Corradini, M. Magni
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
2013 S.L. Locatelli, A. Giacomini, A. Guidetti, L. Cleris, R. Mortarini, A. Anichini, A. Gianni, C. Carlo Stella
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34+ cells
2013 A. Giacomini, M. Righi, L. Cleris, S.L. Locatelli, S. Mitola, M.G. Daidone, A.M. Gianni, C. Carlo-Stella
Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatment
2013 P. Giannatempo, B. Paolini, R. Miceli, D. Raggi, N. Nicolai, E. Faré, M. Catanzaro, D. Biasoni, T. Torelli, S. Stagni, L. Piva, L. Mariani, R. Salvioni, M. Colecchia, A.M. Gianni, A. Necchi
Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies
2013 M. Marconi, B. Ascione, L. Ciarlo, R. Vona, T. Garofalo, M. Sorice, A.M. Gianni, S.L. Locatelli, C. Carlo-Stella, W. Malorni, P. Matarrese